NCT01810250

Brief Summary

The Department of Vascular Surgery at Catharina Hospital Eindhoven, The Netherlands initiates the Endurant for Challenging Anatomy: Global Experience (EAGLE) Registry. The aim of this study is to collect clinical information on the performance of the Endurant Stent Graft System for endovascular repair in anatomically challenging aneurysms, and to critically assess whether the current guidelines for anatomic eligibility to endovascular treatment with this system are still applicable. This study aims at creating a database that can be pooled/ compared with the ENGAGE database. This study aims at answering two major questions:

  1. 1.Is the technical success rate of successful delivery and deployment of the Endurant (II) similar in anatomically challenging aneurysm?
  2. 2.Is the successful treatment rate comparable in anatomically challenging aneurysms, or does treatment of these aneurysms lead to more complications and reinterventions?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 12, 2013

Completed
29 days until next milestone

First Posted

Study publicly available on registry

March 13, 2013

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
5.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

December 26, 2023

Status Verified

December 1, 2023

Enrollment Period

5.2 years

First QC Date

February 12, 2013

Last Update Submit

December 20, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical success

    Freedom from: * Increase of AAA diameter \> 5 mm (1 month measurement as baseline) * Type I\&III endoleaks * Aneurysm rupture * Conversion to surgery * Stent graft migration (\>10mm) resulting in SAE or reintervention * Stent graft occlusion

    12 months

Secondary Outcomes (1)

  • Helath Related Quality of Life Scores

    12 months

Study Arms (1)

Abdominal Aortic Aneurysm (Challenging anatomy)

Endovascular aneurysm repair

Device: Endurant Stent Graft

Interventions

Abdominal Aortic Aneurysm (Challenging anatomy)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with abdominal aortic aneurysms (AAAs) with challenging anatomy defined by having one or more of the following measurements: * Proximal necks 5 - 10mm in combination with \< 60 degrees infrarenal AND \< 45 degrees suprarenal angulation * Proximal necks 10 - 15mm in combination with 60 degrees - 75 degrees infrarenal AND \< 60 degrees suprarenal angulation OR in combination with \< 75 degrees infrarenal AND 45 degrees - 60 degrees suprarenal angulation * Proximal necks \> 15mm in combination with 75 degrees - 90 degrees infrarenal AND \< 75 degrees suprarenal angulation OR in combination with \< 90 degrees infrarenal AND 60 degrees - 75 degrees suprarenal angulation

You may qualify if:

  • Age ≥ 18 years or minimum age as required by local regulations
  • Indication for elective EVAR
  • Challenging AAA anatomy
  • Intention to electively implant the Endurant or Endurant II Stent Graft System©
  • Signed informed consent form

You may not qualify if:

  • Subjects with intolerance to contrast media
  • Chimneys or fenestrated device procedures
  • High probability of non-adherence to physician's follow-up requirements
  • Current participation in a concurrent trial that may confound study results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catharina Ziekenhuis

Eindhoven, North Brabant, 5602 ZA, Netherlands

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

February 12, 2013

First Posted

March 13, 2013

Study Start

November 1, 2012

Primary Completion

January 1, 2018

Study Completion

May 1, 2023

Last Updated

December 26, 2023

Record last verified: 2023-12

Locations